Deontics Clinical Decision Support Systems (CDSS), developed at Oxford University and University College London, promote evidence-based and personalized medicine. We believe Deontics CDSS have the most sophisticated capability in the world to integrate individual patient data with clinical guidelines and so create highly sophisticated individualized treatment recommendations, workflow, quality alerts, prognostication, clinical trial eligibility alerts etc.. Outputs from Deontics CDSS can be used by clinicians, patients and administrators for personalised clinical practice and audit.
Deontics has built a range of CDSS apps e.g. Breast, Lung, Colon, Prostate cancers, to facilitate Tumor Board decision making. Deontics CDSS can also be configured for non-cancer conditions and Deontics has also built apps for treatment of Thyroid Nodules, Cerebral Aneurysm, Pediatric A&E, Myocardial Infarction.
Deontics CDSS apps are fully transparent and highly intuitive to clinicians.